Preparation and Characterization of Sodium Alginate-reduced Graphene Oxide Microbeads for Co-Delivery of Doxorubicin and 5-Fluorouracil

D. Ganesh,Reddy O. Sreekanth,P. Suresh,Rao G. Srinivasa

DOI: https://doi.org/10.25303/2605rjce7886

2022-04-25

Research Journal of Chemistry and Environment

Abstract:Combination therapy has gained significant interest in recent years due to its potential to produce greater therapeutic success than mono-drug therapy. However, carriers capable of effective and stimuli-responsive codelivery of several drugs are severely lacking at the time. To address this need, the study represents the fabrication of reduced graphene oxide-sodium alginate microbeads for co-delivery and controlled release of doxorubicin (DOX) and 5-fluorouracil (5-FU). The developed beads were characterized by Fourier transform infrared spectroscopy (FTIR), Differential scanning calorimetry (DSC), Thermogravimetric analysis (TGA), X-ray diffraction (XRD) and Scanning electron microscopy (SEM). Swelling and in vitro drug release experiments were performed at pH 7.4, 5.4 and 1.2 at 37 °C. The findings indicated that the pH of the test media could be appropriate for intestinal drug delivery. The release process was studied with the release data being integrated into the Korsmeyer-Peppas equation. The presence of rGO in the polymeric matrix influences the drug release rate. The anticancer activity of the alginate beads was assessed using an MTT assay against MCF-7 cells. The findings indicate that the dual-drug containing microbeads showed good activity compared to 5-FU loaded microbeads. The results showed that the developed microbeads warrant further development for applications that require simultaneous administration of multiple bioactive agents.